Trastuzumab, CAS 180288-69-1

Product Description: Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Sliwkowski MX, et al. Nonclinical studies addressing the mechanism of action of trastuzumab. Semin Oncol. 1999 Aug;26(4 Suppl 12):60-70./[2]Hudis CA, et al. Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med. 2007 Jul 5;357(1):39-51./[3]Barok M, et al. Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance. Mol Cancer Ther. 2007 Jul;6(7):2065-72.

CAS Number: 180288-69-1

Molecular Weight: N/A

Compound Purity: 99.80

Research Area: Cancer

Solubility: H2O

Target: ADC Antibody;EGFR

• SKU: MEXHY-P9907-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9907-1
• Green Labware: No
• Package Unit: 1 mg
• Quantity Unit: STK